Ethics roundtable debate: Patients and surrogates want 'everything done' – what does 'everything' mean?

Christopher Doig1, Holt Murray2, Rinaldo Bellomo3, Michael Kuiper4, Rubens Costa5, Elie Azoulay6, David Crippen7
1Department of Critical Care Medicine, University of Calgary, Calgary, Canada
2Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, USA
3Department of Intensive Care, Department of Medicine, University of Melbourne, Melbourne, Australia
4Department of Intensive Care Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands
5Critical Care Department, Hospital Pró Cardíaco, Rio de Janeiro, Brazil
6Service de Réanimation Médicale, Hôpital Saint-Louis et Université Paris 7, Paris, France
7Neurovascular ICU, Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA

Tóm tắt

Highly complex and specialized care plans sometimes overwhelm the comprehension of patients and families. Many optimistic surrogates of critically ill patients err on the side of desiring that everything be done but with a nebulous idea of what 'everything' entails. Physicians must work closely to educate surrogates as to the benefits versus the risks of treatment. Our roundtable experts ponder the question of whether providers possess the authority to interpret unilaterally the nature of requests for everything.

Từ khóa


Tài liệu tham khảo

Canadian Medical Association: Code of Ethics. Ottawa: The Canadian Medical Association; 1996.

Anonymous: Joint statement on resuscitative interventions (update 1995). CMA policy summary. CMAJ 1995, 153: 1652A-1652C.

Weijer C: Cardiopulmonary resuscitation for patients in a persistent vegetative state: futile or acceptable? CMAJ 1998, 158: 491-493.

Baylis F: Expert testimony by persons trained in ethical reasoning: the case of Andrew Sawatzky. J Law Med Ethics 2000, 28: 224-231.

Picard EI, Robertson GB: Legal Liability of Doctors andHospitals in Canada. 3rd edition. Toronto: Carswell; 1996:265.

Weijer C, Singer PA, Dickens BM, Workman S: Bioethics for clinicians: 16. Dealing with demands for inappropriate treatment. CMAJ 1998, 159: 817-821.

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 24: 777-785. 10.1056/NEJMoa042991

Steiner T, Rosand J, Diringer M: Intracerebral hemorrhage associated with oral anticoagulant therapy. Current practices and unresolved questions. Stroke 2006, 37: 256-262. 10.1161/01.STR.0000196989.09900.f8

Gillon R: Medical ethics: four principles plus attention to scope. BMJ 1994, 309: 184-188.